京津冀“3+N”联盟集采启动：西药、中成药带量联动采购，推动仿制药企业加大研发投入

七印授权

4ML03HUC804GOS1C7B48L3ELUGBY2XL8MIK68982TG2ZCH7SEE

2023-09-06 09:41:58

article

54B420A6D86638BDB9F0E510D86401329E781E9206786930EA9A192730AC2521

zh-CN

810C6AC3DBE42EC737C2BFAC2D1B6C124E284D4A

15203703

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

7b67b0329e7d54d0c199ea3354de5092ba350af5ed07a07d4fc30c722ea7015b1d80b7dc2a06560d57e2f7665536d7087af89b3a4de635b7b13e5e0e6da5afaf1c

{"parameters":{"adaptation":"n","price":"180000"},"type":"cm"}

yuanben_64f849663d0f93.76280701

原本认证

https://www.yuanben.io/article/c4323459-087d-420d-bdfc-f292d07d0e27

{"author":"广东南方财经控股有限公司","authorization_pub_key":"03db333a8335fc94ab2e27ec5b937827ece2e576ae219f93ea1083a9a4f8882dc2"}